BioCentury
ARTICLE | Financial News

AI play BioXcel raises $60M IPO

March 8, 2018 7:25 PM UTC

BioXcel Therapeutics Inc. (NASDAQ:BTAI) gained $0.03 to $11.03 Thursday after the artificial intelligence company raised $60 million through the sale of 5.5 million shares at $11 in an upsized IPO underwritten by Barclays, UBS, BMO and Canaccord Genuity. The price valued the company at $172.1 million. BioXcel priced the offering at the bottom of its proposed $11-$13 range; it said earlier this week it hoped to sell 5 million shares...

BCIQ Company Profiles

BioXcel Therapeutics Inc.